Nicotine as a typical drug of abuse in experimental animals and humans

被引:91
|
作者
Le Foll, B [1 ]
Goldberg, SR [1 ]
机构
[1] NIDA, Preclin Pharmacol Sect, Behav Neurosci Res Branch, NIH,Dept Hlth & Human Serv, Baltimore, MD 21224 USA
关键词
D O I
10.1007/s00213-005-0155-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale and background: Tobacco use through cigarette smoking is the leading preventable cause of death in the developed world. Nicotine, a psychoactive component of tobacco, appears to play a major role in tobacco dependence, but reinforcing effects of nicotine often are difficult to demonstrate directly in controlled laboratory studies with animal or human subjects. Objective: To review the major findings obtained with various procedures developed to study dependence-related behavioral effects of nicotine in experimental animals and humans, i.e., drug self-administration, conditioned place preference, subjective reports of nicotine effects and nicotine discrimination, withdrawal signs, and ratings of drug withdrawal. Results: Nicotine can function as an effective reinforcer of drug-seeking and drug-taking behavior both in experimental animals and humans under appropriate conditions. Interruption of chronic nicotine exposure produces withdrawal symptoms that may contribute to relapse. Difficulties encountered in demonstrating reinforcing effects of nicotine under some conditions, relative to other drugs of abuse, may be due to weaker primary reinforcing effects of nicotine or to a more critical contribution of environmental stimuli to the maintenance of drug-seeking and drug-taking behavior with nicotine than with other drugs of abuse. Further experiments are also needed to delineate the role other chemical substances inhaled along with nicotine in tobacco smoke play in sustaining smoking behavior. Conclusions: Nicotine acts as a typical drug of abuse in experimental animals and humans.
引用
收藏
页码:367 / 381
页数:15
相关论文
共 50 条
  • [21] SOLVENT NEPHROTOXICITY IN HUMANS AND EXPERIMENTAL-ANIMALS
    NELSON, NA
    ROBINS, TG
    PORT, FK
    AMERICAN JOURNAL OF NEPHROLOGY, 1990, 10 (01) : 10 - 20
  • [22] NUTRIENT BIOAVAILABILITY IN HUMANS AND EXPERIMENTAL-ANIMALS
    GODBER, JS
    JOURNAL OF FOOD QUALITY, 1990, 13 (01) : 21 - 36
  • [23] Teratogenicity and embryotoxicity of metals in humans and experimental animals
    Sunderman, FW
    METAL IONS IN BIOLOGY AND MEDICINE, VOL 5, 1998, 5 : 275 - 279
  • [24] Genetics of hypertension: From experimental animals to humans
    Delles, Christian
    McBride, Martin W.
    Graham, Delyth
    Padmanabhan, Sandosh
    Dominiczak, Anna F.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (12): : 1299 - 1308
  • [25] The actions of exogenous dehydroepiandrosterone in experimental animals and humans
    Svec, F
    Porter, JR
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1998, 218 (03): : 174 - 191
  • [26] CARDIAC STEROID KINETICS IN HUMANS AND EXPERIMENTAL ANIMALS
    RUIZTORRES, A
    KLINISCHE WOCHENSCHRIFT, 1970, 48 (05): : 257 - +
  • [28] Principles of drug abuse liability assessment in laboratory animals
    Ator, NA
    Griffiths, RR
    DRUG AND ALCOHOL DEPENDENCE, 2003, 70 (03) : S55 - S72
  • [29] Substance abuse in middle and old age - everyday drug alcohol and nicotine: use and abuse
    Ettrich, KU
    Fischer-Cyrulies, A
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2005, 38 (01): : 47 - 59
  • [30] An overview of nicotine use disorders for alcohol/drug abuse clinicians
    Hughes, JR
    AMERICAN JOURNAL ON ADDICTIONS, 1996, 5 (03): : 262 - 274